GlassScriptPhysician profile
Matthew A Ward
NPI 1417342700
$2,571.07
in general payments reported to CMS, 2019-2025
37 companies · $278 in 2025
The $278 reported for 2025 was less than what a typical Foot & Ankle Surgery provider received nationally (typical 2025 total: $424).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $380 · 2020: $170 · 2021: $248 · 2022: $339 · 2023: $886 · 2024: $269 · 2025: $278.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,364 · Education: $68.87.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,364.10 |
| Education | $68.87 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Horizon Therapeutics Plc | $399.16 | 2019-2023 | Krystexxa |
| Stryker Corporation | $280.48 | 2023-2025 | Augment Injectable, Prophecy, Fixos |
| Treace Medical Concepts, INC. | $277.59 | 2024-2025 | |
| Organogenesis INC. | $147.59 | 2023 | Puraply Antimicrobial, Puraply |
| Depuy Synthes Sales INC. | $132.20 | 2020-2024 | |
| Medline Industries LP | $96.80 | 2023 | |
| Polynovo North America LLC | $89.11 | 2023 | |
| Progenacare Global, LLC | $88.90 | 2023 | |
| Dynasplint Systems INC. | $88.90 | 2019-2022 | |
| Bioventus LLC | $87.63 | 2019-2021 | |
| Polymedics Innovations INC. | $78.23 | 2023 | |
| Averitas Pharma INC. | $69.67 | 2023-2025 | Qutenza |
| Mimedx Group, INC. | $64.31 | 2024-2025 | |
| Triad Life Sciences INC. | $61.90 | 2022 | |
| Paratek Pharmaceuticals, INC. | $61.85 | 2023-2025 | Nuzyra |
Show all 37 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Kerecis Limited | $48.05 | 2019-2022 | |
| Osteomed LLC | $39.44 | 2019 | |
| Smith+Nephew, INC. | $39.38 | 2019-2021 | |
| Pacira Pharmaceuticals Incorporated | $38.80 | 2019-2024 | Exparel |
| Integra Lifesciences Corporation | $37.66 | 2021-2023 | Integra, Primatrix, Integra Dermal Regeneration Template |
| Zimvie INC. | $36.87 | 2022-2023 | |
| Ortho Dermatologics, A Division of Bausch Health US, LLC | $33.83 | 2019 | |
| Orthofix Medical, INC. | $31.16 | 2019-2022 | |
| Paragon 28, INC. | $28.93 | 2019-2020 | |
| Grt US Holding, INC. | $23.04 | 2021 | |
| Medtronic, INC. | $22.88 | 2024 | Venaseal |
| Nevro Corp. | $22.78 | 2023 | Senza |
| Kci USA, INC. | $20.66 | 2020 | |
| Metric Medical Devices, INC. | $17.60 | 2019 | |
| Biocomposites INC | $16.28 | 2023 | Stimulan |
| Next Science LLC | $14.14 | 2021 | |
| Zimmer Biomet Holdings, INC. | $13.99 | 2020 | |
| Djo, LLC | $13.72 | 2025 | Cmf |
| Baudax Bio INC. | $13.68 | 2022 | |
| Acell, INC. | $11.75 | 2019 | |
| Merck Sharp & Dohme LLC | $11.24 | 2019 | |
| Reprise Biomedical, INC. | $10.87 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Matthew Ward listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.